Patent 11021737

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-pro

No PTAB proceedings on file. This patent has not been challenged through Inter Partes Review, Post-Grant Review, or Covered Business Method review at the USPTO. The absence is itself a signal — well-asserted patents eventually attract IPRs.

Cases on file (3)

Group view →

Specific litigation cases in our database that name US patent 11021737. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

Known Litigation Involving U.S. Patent 11,021,737

As of May 12, 2026, U.S. Patent 11,021,737 is asserted in multiple patent infringement lawsuits, reflecting its significance in the competitive spatial biology market. The exclusive licensee, 10x Genomics, Inc., alongside patent owner President and Fellows of Harvard College, has actively enforced this patent against competitors.

Case 1: Action Against Vizgen Inc.

  • Plaintiff(s): 10x Genomics, Inc. and President and Fellows of Harvard College
  • Defendant(s): Vizgen, Inc.
  • Jurisdiction: U.S. District Court for the District of Delaware
  • Case Number: 1:22-cv-00595
  • Filing Date: May 4, 2022
  • Outcome or Current Status: Settled. This complex case involved claims of infringement by 10x and Harvard, with Vizgen filing counterclaims for non-infringement, invalidity, and antitrust violations. After extensive legal proceedings, the parties reached a settlement in early February 2025, resolving the global patent dispute. The terms of the settlement were not publicly disclosed.

Case 2: Action Against NanoString Technologies, Inc.

  • Plaintiff(s): 10x Genomics, Inc. and President and Fellows of Harvard College
  • Defendant(s): NanoString Technologies, Inc.
  • Jurisdiction: U.S. District Court for the District of Delaware
  • Case Number: 1:22-cv-00261
  • Filing Date: February 28, 2022.
  • Outcome or Current Status: Active. While this case involves a broader dispute over multiple spatial technology patents, US 11,021,737 is part of the litigation. The case is ongoing, with proceedings linked to the related action against Vizgen (1:22-cv-00595) before that case was settled. Detailed current status would require review of the most recent court filings on PACER.

Case 3: Action Against Element Biosciences, Inc.

  • Plaintiff(s): 10x Genomics, Inc. and President and Fellows of Harvard College
  • Defendant(s): Element Biosciences, Inc.
  • Jurisdiction: U.S. District Court for the District of Delaware
  • Case Number: 1:2026cv00538
  • Filing Date: May 8, 2026.
  • Outcome or Current Status: Newly filed. The complaint alleges that Element's AVITI24 multiomic analysis platform infringes on patent 11,021,737 and three other related patents. Element Biosciences has stated its intent to "vigorously defend its technology." As a new filing, this case is in its earliest stages.

Generated 5/12/2026, 12:49:02 PM